Weekly 70mg oral alendronate therapy in postmenopausal osteopenic women.
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2011
At a glance
- Drugs Alendronic acid (Primary) ; Calcium; Colecalciferol
- Indications Metabolic bone diseases; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 12 Jun 2011 Results presented at the 13th World Congress on Menopause.
- 05 Nov 2010 New trial record.